Shenyang Xingqi Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd Price to Book Ratio (P/B) on January 14, 2025: 7.12

Shenyang Xingqi Pharmaceutical Co.,Ltd Price to Book Ratio (P/B) is 7.12 on January 14, 2025, a -40.26% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Shenyang Xingqi Pharmaceutical Co.,Ltd 52-week high Price to Book Ratio (P/B) is 21.23 on May 14, 2024, which is 198.32% above the current Price to Book Ratio (P/B).
Shenyang Xingqi Pharmaceutical Co.,Ltd 52-week low Price to Book Ratio (P/B) is 6.50 on January 09, 2025, which is -8.68% below the current Price to Book Ratio (P/B).
Shenyang Xingqi Pharmaceutical Co.,Ltd average Price to Book Ratio (P/B) for the last 52 weeks is 11.22.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd

CEO	Ms. E. Gao
IPO Date	Dec. 9, 2016
Location	China
Headquarters	No. 68, Lishui Street
Employees	1,995
Sector	Health Care
Industries Pharmaceuticals Cosmetics Eyewear

Description

Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Key trends

Past 5 years